Provided by Tiger Trade Technology Pte. Ltd.

Allogene Therapeutics Inc.

1.71
-0.0150-0.87%
Volume:3.26M
Turnover:5.64M
Market Cap:588.23M
PE:-2.62
High:1.77
Open:1.74
Low:1.70
Close:1.72
52wk High:4.46
52wk Low:1.04
Shares:345.00M
Float Shares:262.00M
Volume Ratio:0.78
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6510
EPS(LYR):-0.8652
ROE:-42.39%
ROA:-22.08%
PB:1.35
PE(LYR):-1.97

Loading ...

Sep 02, 2026

Major Issues Report

Form 8-K - Current report
Aug 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jun 22, 2026

Major Issues Report

Form 8-K - Current report
May 28, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2026

Major Issues Report

Form 8-K - Current report
Apr 23, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 15, 2026

Major Issues Report

Form 8-K - Current report
Apr 13, 2026

Major Issues Report

Form 8-K - Current report
Apr 13, 2026

Major Issues Report

Form 8-K - Current report